← Back to all trials
Recruiting
NCT05842330
Benefits of ADHD Treatment in Detained People
Conditions: ADHD
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE3
Enrollment: 150
Sponsor: Stéphanie Baggio
Location: Geneva University Hospitals Geneva Canton of Geneva
Summary
Attention deficit hyperactivity disorder (ADHD) is characterized by difficulties paying attention, poor impulse control, and hyperactive behaviors. It is associated with several health and social detrimental outcomes and leads to increased risks of criminality and recidivism. However, to date, ADHD treatment has been neglected in prison. This project will test the efficacy of ADHD treatment using a randomized controlled trial.
Eligibility Criteria
Inclusion Criteria:
* age between 18 and 65
* good command of French
* stay in prison approx. 4 months at eligibility visit
* endorsing clinical diagnostic criteria for DSM-5 ADHD
* providing written informed consent
Exclusion Criteria:
* presence of an acute uncontrolled comorbid psychiatric disorder
* medical contraindication to stimulant prescription
* potential adverse interaction with another medication
* already receive ADHD treatment
Source: ClinicalTrials.gov (NCT05842330). StuddyBuddy aggregates publicly available trial information.
